medigraphic.com
ISSN 2448-5640 (Print)
Diario Oficial de la Sociedad Mexicana de Cirugía Cardiaca, A.C., y del Colegio Mexicano de Cirugía Cardiovascular y Torácica, A.C.

2017, Number 3

<< Back Next >>

Cir Card Mex 2017; 2 (3)

Cirugía valvular mitral por MICS. Experiencia de 4 años

Roldán-Morales D, Álvarez-Bestoff G, Barragán-Zamora A, López-Gutiérrez A, Ramírez-Castañeda A, Riera-Kinkel C

Language: Spanish
References: 11
Page: 85-88
PDF size: 138.97 Kb.


ABSTRACT

Objective. We review the results of the mitral surgery through a minimally invasive approach in our center within a four year period.
Material and methods. A retrospective review of all the cases of patients treated with mitral valve surgery through a minimally invasive approach during may 2013 and September 2016 were made. Demographic data were collected, the hospital length of stay, intensive care unit length of stay, cardiopulmonary bypass time and aortic clamp time, surgical bleeding, postoperative bleeding, use of blood components, surgical time, mechanical ventilation support and postoperative complications were registered.
Results. A total of 881 mitral valve procedures were made in the study period, 37 through a minimally invasive approach. The median age was 54.3 years (range, 27-72 years), BMI 27.6 kg/m2 (range, 21.2-33.5 kg/m2). Systemic hypertension was present in 35% of patients, diabetes mellitus 15%, dyslipidemia 25%, smoking 20% and atrial fibrillation in 65%. The average length of stay was 7 days, intensive care unit stay 3 day. Median operative bleeding was 168.7 ml and postoperative bleeding 326 ml. The average cardiopulmonary bypass time was 135 minutes, with an average of aortic cross-clamping time of 91.8 minutes. No deaths occurred.
Conclusions. Mitral valve surgery through a minimally invasive approach is a safe and effective option for the treatment of patients with mitral valve disease.


REFERENCES

  1. Falk V, Cheng DCH, Martin J, et al. Minimally Invasive Versus Open Mitral ValveSurgery: A Consensus Statement of the International Society of Minimally InvasiveCoronary Surgery (ISMICS) 2010. Innovations: Technology & Techniques inCardiothoracic & Vascular Surgery 2011; 6: 66-76.

  2. Subramanian S, Seeburger J, Noack T, Mohr FW, Coselli JS. Future Perspectivesin Minimally Invasive Cardiac Surgery. Tex Heart Inst J 2011; 38: 678- 9.

  3. Vollroth M, Seeburger J, Garbade J, et al. Minimally invasive mitral valve surgeryis a very safe procedure with very low rates of conversion to full sternotomy. EurJ Cardiothorac Surg 2012;42:e13-5.

  4. Modi P, Hassan A, Chitwood WR Jr. Minimally invasive mitral valve surgery: asystematic review and meta-analysis. Eur J Cardiothorac Surg 2008;34:943-52.

  5. Iribarne A, Russo MJ, Easterwood R, et al. Minimally invasive versus sternotomyapproach for mitral valve surgery: a propensity analysis. Ann Thorac Surg2010;90:1471-7.

  6. Holzhey DM, Shi W, Borger MA, et al. Minimally invasive versus sternotomyapproach for mitral valve surgery in patients greater than 70 years old: A propensity-matched comparison. Ann Thorac Surg 2011;91:401-5.

  7. Gammie JS, Zhao Y, Peterson ED, O’Brien SM, Rankin JS, Griffith BP. Less-invasivemitral valve operations trends and outcomes from the society of thoracicsurgeons adult cardiac surgery database. Ann Thorac Surg. 2010;90:1401-10.

  8. Woo YJ, Joerg S, Friedrich WM. Minimally invasive valve surgery. Semin ThoracCardiovasc Surg 2007;19:289-98.

  9. Czesla M, Götte J, Weimar T, Ruttkay T, Doll N. Safeguards and pitfalls in minimallyinvasive mitral valve surgery. Ann Cardiothorac Surg 2013;2:849-52.

  10. Mohr, F.W, Onnasch, J.F, Falk, V et al, The evolution of minimally invasive mitralvalve surgery—2 year experience. Eur J Cardiothorac Surg. 1999;15:233-9.

  11. Vollroth M, Seeburger J, Garbade J, Borger MA, Misfeld M, Mohr FW. Conversionrate and contraindications for minimally invasive mitral valve surgery. AnnCardiothorac Surg 2013; 2: 853-4.




2020     |     www.medigraphic.com